Go to content
OctoPlus N.V.

OctoPlus N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 26 apr 2007 - 23:19
Statutaire naam OctoPlus N.V.
Titel OctoPlus announces analyst meeting on May 1
Bericht OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), the drug delivery and development company, announces today that it will host an analyst meeting on May 1. The Company invites analysts to attend the meeting in Leiden at 13:30 PM CET on Tuesday, May 1 2007. OctoPlus’ senior management will present a comprehensive overview of the Company’s strategy, product development and clinical development status. Analysts who would like to attend the meeting should confirm their attendance via email to IR@octoplus.nl. Presentations from this meeting will be available from OctoPlus’ website on May 2nd.

Datum laatste update: 19 april 2026